The biomarker mid-regional pro-adrenomedullin drawn upon admission for ST-elevation myocardial infarction is a strong predictor of 30-day mortality

3 March 2019 (11:45 - 12:00)
Organised by:
Congress Presentation Part of: Young Investigator Awards Abstracts ST-Elevation Myocardial Infarction (STEMI) ACVC Premium Access Acute Cardiovascular Care 2019

ESC 365 is supported by

ESC 365 is supported by